Bacteria are held responsible for a significant proportion of chronic obstructive pulmonary disease (COPD) exacerbations although demonstration of appreciable beneficial effects following antibiotic treatment has been difficult to obtain. Recent evidence suggests that antimicrobial treatment is not indicated in all COPD patients with exacerbations and that adequate patient stratification is essential. Among the factors associated with greatest benefit following antibiotic therapy are sputum purulence, patient severity, and presence of comorbidities. It is now recognized that exacerbation microbiology varies with baseline disease severity, with Gram-negative bacteria and Pseudomonas aeruginosa more commonly encountered in more severely compromised patients. Antibiotic selection must take into consideration patient characteristics and probable etiologic agents. A significant number of COPD patients have persistent airway bacterial colonization outside exacerbation episodes. Recently, prophylactic antibiotic use in these patients has recently received renewed attention.

Antibiotic therapy and prophylaxis in COPD / F. Blasi, P. Tarsia, M. Pappalettera, M. Saporiti, S. Aliberti. - In: RESPIRATORY MEDICINE. - ISSN 1745-0454. - 2:4(2007), pp. 124-132.

Antibiotic therapy and prophylaxis in COPD

F. Blasi;S. Aliberti
2007

Abstract

Bacteria are held responsible for a significant proportion of chronic obstructive pulmonary disease (COPD) exacerbations although demonstration of appreciable beneficial effects following antibiotic treatment has been difficult to obtain. Recent evidence suggests that antimicrobial treatment is not indicated in all COPD patients with exacerbations and that adequate patient stratification is essential. Among the factors associated with greatest benefit following antibiotic therapy are sputum purulence, patient severity, and presence of comorbidities. It is now recognized that exacerbation microbiology varies with baseline disease severity, with Gram-negative bacteria and Pseudomonas aeruginosa more commonly encountered in more severely compromised patients. Antibiotic selection must take into consideration patient characteristics and probable etiologic agents. A significant number of COPD patients have persistent airway bacterial colonization outside exacerbation episodes. Recently, prophylactic antibiotic use in these patients has recently received renewed attention.
Antibiotics; COPD; Exacerbations; Prophylaxis
Settore MED/10 - Malattie dell'Apparato Respiratorio
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S174504540600222X-main.pdf

non disponibili

Tipologia: Publisher's version/PDF
Dimensione 203.42 kB
Formato Adobe PDF
203.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/51860
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact